A startup with ties to Bayer has inked a $122 million deal to make lab-grown marijuana — and it's eyeing the pharma industry (Business Insider)

Ginkgo Bioworks, a startup known for its work turning bacteria into consumer goods, is partnering with marijuana producer Cronos to make lab-grown cannabis.
The $122-million deal, announced this week, will allow Ginkgo to use Cronos' Canadian lab space to make several different marijuana compounds without a farm.
Ginkgo's CEO told Business Insider the deal could have big potential for the pharmaceutical industry, who's been hard at work turning marijuana compounds into medications. https://www.businessinsider.com/marijuana-gingko-bioworks-cronos-lab-grown-cannabis-pharma-2018-9, 5.9.2018